Myricx Bio Alternatives & Competitors
12 companies similar to Myricx Bio — Developing a new class of ADCs based on NMT inhibition to treat cancer
Companies similar to Myricx Bio
Iksuda Therapeutics
Creating class-leading ADCs with enhanced tumor specificity
Newcastle Upon Tyne, Unit...
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Toronto, Canada
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...
ONA Therapeutics
First-in-class ADCs tailored to attack advanced cancer
Barcelona, Spain
Rival Readout
Competing with Myricx Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
PineTree Therapeutics Inc
Disruptive Innovations to Treat Unmet Therapeutic Needs in Oncology
Cambridge, United States
Germany
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Synnovation Therapeutics
A precision oncology company focused on small molecule therapies optimized to target key d...
Wilmington, United States
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
London, United Kingdom
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
About Myricx Bio
Myricx Bio is an innovative UK-based biotech company, established in 2019, with a mission to revolutionize cancer treatment through their novel technology. The company's tagline, "Developing a new class of ADCs based on NMT inhibition to treat cancer," reflects its pioneering approach in creating selective cytotoxic pa...
Discovery and development of novel ADCs, Preclinical efficacy and safety testing, Clinical team expansion and regulatory affairs
Oncologists, Pharmaceutical companies, Biotechnology partners, Research institutions
Biotech, Antibody Drug Conjugates, ADC Development, N-Myristoyltransferase Inhibitors, NMT Inhibition, Oncology Treatment, Cytotoxic Payload Development, Small Molecule Drug Discovery, Cancer Therapy, Preclinical Efficacy, Drug Development Pipeline, Targeted Cancer Therapy, Novel Therapeutic Modalities, Solid Tumor Antigens
B2B
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Myricx Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Myricx Bio on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
